Difficulty distinguishing essential thrombocythaemia from polycythaemia vera in children with JAK2 V617F-positive myeloproliferative neoplasms

被引：15

作者：

Kucine, Nicole ^{[1
]}

Al-Kawaaz, Mustafa ^{[2
]}

Hajje, Daher ^{[2
]}

Bussel, James ^{[1
]}

Orazi, Attilio ^{[2
]}

机构：

[1] Weill Cornell Med Coll, Dept Pediat, Div Pediat Hematol Oncol, New York, NY 10065 USA

[2] Weill Cornell Med Coll, Dept Pathol & Lab Med, Div Hematopathol, New York, NY USA

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2019年 / 185卷 / 01期

基金：

美国国家卫生研究院;

关键词：

myeloproliferative neoplasm; essential thrombocythaemia; polycythaemia vera; paediatric haematology; TYROSINE KINASE JAK2; MUTATION STATUS; SUBTYPES;

D O I：

10.1111/bjh.15386

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：136 / 139

页数：4

共 8 条

[1] The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
Arber, Daniel A.
Orazi, Attilio
Hasserjian, Robert
Thiele, Jurgen
Borowitz, Michael J.
Le Beau, Michelle M.
Bloomfield, Clara D.
Cazzola, Mario
Vardiman, James W.
[J]. BLOOD, 2016, 127 (20) : 2391 - 2405
[2] Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
Baxter, EJ
Scott, LM
Campbell, PJ
East, C
Fourouclas, N
Swanton, S
Vassiliou, GS
Bench, AJ
Boyd, EM
Curtin, N
Scott, MA
Erber, WN
Green, AR
[J]. LANCET, 2005, 365 (9464) : 1054 - 1061
[3] Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status:: a prospective study
Campbell, PJ
Scott, LM
Buck, G
Wheatley, K
East, CL
Marsden, JT
Duffy, A
Boyd, EM
Bench, AJ
Scott, MA
Vassiliou, GS
Milligan, DW
Smith, SR
Erber, WN
Bareford, D
Wilkins, BS
Reilly, JT
Harrison, CN
Green, AR
[J]. LANCET, 2005, 366 (9501) : 1945 - 1953
[4] Cembrowski G.S., 2005, LAB HEMATOLOGY, V10, P245
[5] HARTSOCK RJ, 1965, AM J CLIN PATHOL, V43, P326
[6] Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
Levine, RL
Wadleigh, M
Cools, J
Ebert, BL
Wernig, G
Huntly, BJP
Boggon, TJ
Wlodarska, L
Clark, JJ
Moore, S
Adelsperger, J
Koo, S
Lee, JC
Gabriel, S
Mercher, T
D'Andrea, A
Fröhling, S
Döhner, K
Marynen, P
Vandenberghe, P
Mesa, RA
Tefferi, A
Griffin, JD
Eck, MJ
Sellers, WR
Meyerson, M
Golub, TR
Lee, SJ
Gilliland, DG
[J]. CANCER CELL, 2005, 7 (04) : 387 - 397
[7] JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes
Rumi, Elisa
Pietra, Daniela
Ferretti, Virginia
Klampfl, Thorsten
Harutyunyan, Ashot S.
Milosevic, Jelena D.
Them, Nicole C. C.
Berg, Tiina
Elena, Chiara
Casetti, Ilaria C.
Milanesi, Chiara
Sant'Antonio, Emanuela
Bellini, Marta
Fugazza, Elena
Renna, Maria C.
Boveri, Emanuela
Astori, Cesare
Pascutto, Cristiana
Kralovics, Robert
Cazzola, Mario
[J]. BLOOD, 2014, 123 (10) : 1544 - 1551
[8] Swerdlow SH, 2017, WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues WHO Classification of Tumours, P39

← 1 →